{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T07:09:45Z","timestamp":1794035385968,"version":"4.8.0"},"reference-count":95,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T00:00:00Z","timestamp":1742860800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003323","name":"ANRS Emerging Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003323","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institutes of Health National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["P01AI131365"],"award-info":[{"award-number":["P01AI131365"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UM1AI164562"],"award-info":[{"award-number":["UM1AI164562"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Med"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.medj.2025.100670","type":"journal-article","created":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T10:35:06Z","timestamp":1745836506000},"page":"100670","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["A genetic fingerprint associated with durable HIV remission after interruption of antiretroviral treatment: ANRS VISCONTI\/PRIMO"],"prefix":"10.1016","volume":"6","author":[{"given":"Asma","family":"Essat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana\u00efs","family":"Chapel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kahina","family":"Amokrane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Monceaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Didier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adeline","family":"Melard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elise","family":"Gardiennet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Avettand-Fenoel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Orr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faroudy","family":"Boufassa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Lambotte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela","family":"M\u00fcller-Trutwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"L\u00e9curoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Ch\u00e9ret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Goujard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Rouzioux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Caillat-Zucman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Hocqueloux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Scott-Algara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2406-7536","authenticated-orcid":false,"given":"Asier","family":"S\u00e1ez-Ciri\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.medj.2025.100670_bib1","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.virol.2014.02.021","article-title":"HIV cure research: advances and prospects","volume":"454\u2013455","author":"Passaes","year":"2014","journal-title":"Virology"},{"key":"10.1016\/j.medj.2025.100670_bib2","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.3851\/IMP2273","article-title":"HIV-1 control after transient antiretroviral treatment initiated in primary infection: role of patient characteristics and effect of therapy","volume":"17","author":"Goujard","year":"2012","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.medj.2025.100670_bib3","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1097\/QAD.0b013e32833b61ba","article-title":"Long-term immunovirologic control following antiretroviral therapy interruption in patients treated at the time of primary HIV-1 infection","volume":"24","author":"Hocqueloux","year":"2010","journal-title":"AIDS"},{"key":"10.1016\/j.medj.2025.100670_bib4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003211","article-title":"Post-treatment HIV-1 controllers with a long-term virological remission after the interruption of early initiated antiretroviral therapy ANRS VISCONTI Study","volume":"9","author":"Saez-Cirion","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.medj.2025.100670_bib5","doi-asserted-by":"crossref","first-page":"e49","DOI":"10.1016\/S2352-3018(15)00232-5","article-title":"HIV-1 virological remission lasting more than 12 years after interruption of early antiretroviral therapy in a perinatally infected teenager enrolled in the French ANRS EPF-CO10 paediatric cohort: a case report","volume":"3","author":"Frange","year":"2016","journal-title":"Lancet. HIV"},{"key":"10.1016\/j.medj.2025.100670_bib6","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/QAD.0000000000002044","article-title":"Virological remission after antiretroviral therapy interruption in female African HIV seroconverters","volume":"33","author":"Gossez","year":"2019","journal-title":"AIDS"},{"key":"10.1016\/j.medj.2025.100670_bib7","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1001\/archinternmed.2012.2719","article-title":"Immunovirologic Control 24 Months After Interruption of Antiretroviral Therapy Initiated Close to HIV Seroconversion","volume":"172","author":"Lodi","year":"2012","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.medj.2025.100670_bib8","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1093\/infdis\/jiy479","article-title":"The Control of HIV After Antiretroviral Medication Pause (CHAMP) Study: Posttreatment Controllers Identified From 14 Clinical Studies","volume":"218","author":"Namazi","year":"2018","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.medj.2025.100670_bib9","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1093\/jac\/dkv084","article-title":"Combined ART started during acute HIV infection protects central memory CD4+ T cells and can induce remission","volume":"70","author":"Cheret","year":"2015","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.medj.2025.100670_bib10","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1038\/s41591-018-0130-7","article-title":"Early antiretroviral therapy limits SIV reservoir establishment to delay or prevent post-treatment viral rebound","volume":"24","author":"Okoye","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.medj.2025.100670_bib11","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/s41467-023-44389-3","article-title":"Early antiretroviral therapy favors post-treatment SIV control associated with the expansion of enhanced memory CD8(+) T-cells","volume":"15","author":"Passaes","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.medj.2025.100670_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007222","article-title":"HIV control: Is getting there the same as staying there?","volume":"14","author":"Goulder","year":"2018","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.medj.2025.100670_bib13","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/imr.12076","article-title":"HIV controllers: a genetically determined or inducible phenotype?","volume":"254","author":"Saez-Cirion","year":"2013","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.medj.2025.100670_bib14","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/s41577-020-0274-9","article-title":"CD8(+) T cells in HIV control, cure and prevention","volume":"20","author":"Collins","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.medj.2025.100670_bib15","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1097\/QAD.0b013e328360a4bd","article-title":"MHC-driven HIV-1 control on the long run is not systematically determined at early times post-HIV-1 infection","volume":"27","author":"Antoni","year":"2013","journal-title":"AIDS"},{"key":"10.1016\/j.medj.2025.100670_bib16","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1126\/science.1195271","article-title":"The major genetic determinants of HIV-1 control affect HLA class I peptide presentation","volume":"330","author":"Pereyra","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.medj.2025.100670_bib17","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1073\/pnas.050567397","article-title":"HLA B\u22175701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors","volume":"97","author":"Migueles","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.medj.2025.100670_bib18","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1126\/science.283.5408.1748","article-title":"HLA and HIV-1: heterozygote advantage and B\u221735-Cw\u221704 disadvantage","volume":"283","author":"Carrington","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.medj.2025.100670_bib19","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1056\/NEJM200105313442203","article-title":"Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDS","volume":"344","author":"Gao","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.medj.2025.100670_bib20","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1097\/QAD.0000000000000322","article-title":"Impact of HLA-B\u221735 subtype differences on HIV disease outcome in Mexico","volume":"28","author":"Juarez-Molina","year":"2014","journal-title":"AIDS"},{"key":"10.1016\/j.medj.2025.100670_bib21","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/iji.12219","article-title":"HLA B51 is associated with faster AIDS progression among newly diagnosed HIV-infected individuals in Manitoba, Canada","volume":"42","author":"Keynan","year":"2015","journal-title":"Int. J. Immunogenet."},{"key":"10.1016\/j.medj.2025.100670_bib22","doi-asserted-by":"crossref","first-page":"12643","DOI":"10.1128\/JVI.01381-12","article-title":"Differential clade-specific HLA-B\u22173501 association with HIV-1 disease outcome is linked to immunogenicity of a single Gag epitope","volume":"86","author":"Matthews","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.medj.2025.100670_bib23","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1097\/QAD.0000000000000403","article-title":"HLA-B\u221735-PX and HLA-B\u221735-PY subtype differentiation does not predict observed differences in level of HIV control in a Peruvian MSM cohort","volume":"28","author":"Olvera","year":"2014","journal-title":"AIDS"},{"key":"10.1016\/j.medj.2025.100670_bib24","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/00002030-199304000-00007","article-title":"Progression to AIDS in French haemophiliacs: association with HLA-B35","volume":"7","author":"Sahmoud","year":"1993","journal-title":"AIDS"},{"key":"10.1016\/j.medj.2025.100670_bib25","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/S0140-6736(86)92197-5","article-title":"HLA-ASSOCIATED SUSCEPTIBILITY TO ACQUIRED IMMUNODEFICIENCY SYNDROME IN ITALIAN PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION","volume":"2","author":"Scorza Smeraldi","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/j.medj.2025.100670_bib26","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1097\/QAD.0b013e3282f13823","article-title":"Immunological control of chronic HIV-1 infection: HLA-mediated immune function and viral evolution in adolescents","volume":"21","author":"Bansal","year":"2007","journal-title":"AIDS"},{"key":"10.1016\/j.medj.2025.100670_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008696","article-title":"Selective Upregulation of CTLA-4 on CD8+ T Cells Restricted by HLA-B\u221735Px Renders them to an Exhausted Phenotype in HIV-1 infection","volume":"16","author":"Elahi","year":"2020","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.medj.2025.100670_bib28","doi-asserted-by":"crossref","first-page":"12603","DOI":"10.1128\/JVI.76.24.12603-12610.2002","article-title":"Human immunodeficiency virus type 1 (HIV-1)-specific CD8+-T-cell responses for groups of HIV-1-infected individuals with different HLA-B\u221735 genotypes","volume":"76","author":"Jin","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.medj.2025.100670_bib29","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ebiom.2018.09.022","article-title":"Impact of a single HLA-A\u221724:02-associated escape mutation on the detrimental effect of HLA-B\u221735:01 in HIV-1 control","volume":"36","author":"Murakoshi","year":"2018","journal-title":"EBioMedicine"},{"key":"10.1016\/j.medj.2025.100670_bib30","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1038\/nm1333","article-title":"AIDS restriction HLA allotypes target distinct intervals of HIV-1 pathogenesis","volume":"11","author":"Gao","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.medj.2025.100670_bib31","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1038\/s41591-018-0026-6","article-title":"Rapid HIV RNA rebound after antiretroviral treatment interruption in persons durably suppressed in Fiebig I acute HIV infection","volume":"24","author":"Colby","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.medj.2025.100670_bib32","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/nri1711","article-title":"NK cells in HIV infection: paradigm for protection or targets for ambush","volume":"5","author":"Fauci","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.medj.2025.100670_bib33","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/s41571-020-0426-7","article-title":"Exploring the NK cell platform for cancer immunotherapy","volume":"18","author":"Myers","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.medj.2025.100670_bib34","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/00042560-199511000-00005","article-title":"Natural killer cell immunodeficiency in HIV disease is manifest by profoundly decreased numbers of CD16+CD56+ cells and expansion of a population of CD16dimCD56- cells with low lytic activity","volume":"10","author":"Hu","year":"1995","journal-title":"J. Acquir. Immune Defic. Syndr. Hum. Retrovirol."},{"key":"10.1016\/j.medj.2025.100670_bib35","doi-asserted-by":"crossref","first-page":"15011","DOI":"10.1073\/pnas.2336091100","article-title":"Natural killer cells in HIV-1 infection: dichotomous effects of viremia on inhibitory and activating receptors and their functional correlates","volume":"100","author":"Mavilio","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.medj.2025.100670_bib36","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1365-2249.1992.tb07925.x","article-title":"Natural killer (NK) cell activity during HIV infection: a decrease in NK activity is observed at the clonal level and is not restored after in vitro long-term culture of NK cells","volume":"90","author":"Scott-Algara","year":"1992","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.medj.2025.100670_bib37","doi-asserted-by":"crossref","first-page":"3366","DOI":"10.1182\/blood-2005-03-1100","article-title":"Sequential deregulation of NK cell subset distribution and function starting in acute HIV-1 infection","volume":"106","author":"Alter","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.medj.2025.100670_bib38","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1084\/jem.182.3.789","article-title":"Defective natural immunity: an early manifestation of human immunodeficiency virus infection","volume":"182","author":"Ullum","year":"1995","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.medj.2025.100670_bib39","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/ng934","article-title":"Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS","volume":"31","author":"Martin","year":"2002","journal-title":"Nat. Genet."},{"key":"10.1016\/j.medj.2025.100670_bib40","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/ng2035","article-title":"Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1","volume":"39","author":"Martin","year":"2007","journal-title":"Nat. Genet."},{"key":"10.1016\/j.medj.2025.100670_bib41","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1097\/QAD.0b013e32835861b0","article-title":"Impact of protective killer inhibitory receptor\/human leukocyte antigen genotypes on natural killer cell and T-cell function in HIV-1-infected controllers","volume":"26","author":"Tomescu","year":"2012","journal-title":"AIDS"},{"key":"10.1016\/j.medj.2025.100670_bib42","doi-asserted-by":"crossref","first-page":"5140","DOI":"10.1073\/pnas.071548198","article-title":"Control of HIV-1 viremia and protection from AIDS are associated with HLA-Bw4 homozygosity","volume":"98","author":"Flores-Villanueva","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.medj.2025.100670_bib43","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.1084\/jem.20070695","article-title":"Differential natural killer cell-mediated inhibition of HIV-1 replication based on distinct KIR\/HLA subtypes","volume":"204","author":"Alter","year":"2007","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.medj.2025.100670_bib44","first-page":"315","article-title":"Evidence for the improvement of French VolunteerBone Marrow Donor Registry by using HLA-SBT atthe registration step","volume":"71","author":"Alizadeh","year":"2008","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.medj.2025.100670_bib45","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1007\/BF02421207","article-title":"Genetic and serological heterogeneity of the supertypic HLA-B locus specificities Bw4 and Bw6","volume":"30","author":"Muller","year":"1989","journal-title":"Immunogenetics"},{"key":"10.1016\/j.medj.2025.100670_bib46","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1084\/jem.184.3.913","article-title":"Protection from lysis by natural killer cells of group 1 and 2 specificity is mediated by residue 80 in human histocompatibility leukocyte antigen C alleles and also occurs with empty major histocompatibility complex molecules","volume":"184","author":"Mandelboim","year":"1996","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.medj.2025.100670_bib47","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.humimm.2012.10.029","article-title":"High-resolution HLA haplotype frequencies of stem cell donors in Germany with foreign parentage: How can they be used to improve unrelated donor searches?","volume":"74","author":"Pingel","year":"2013","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.medj.2025.100670_bib48","doi-asserted-by":"crossref","first-page":"eaag1672","DOI":"10.1126\/sciimmunol.aag1672","article-title":"Class I HLA haplotypes form two schools that educate NK cells in different ways","volume":"1","author":"Horowitz","year":"2016","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.medj.2025.100670_bib49","doi-asserted-by":"crossref","first-page":"4951","DOI":"10.4049\/jimmunol.160.10.4951","article-title":"HLA-E surface expression depends on binding of TAP-dependent peptides derived from certain HLA class I signal sequences","volume":"160","author":"Lee","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.medj.2025.100670_bib50","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nri1570","article-title":"MHC class I molecules and kirs in human history, health and survival","volume":"5","author":"Parham","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.medj.2025.100670_bib51","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.3389\/fimmu.2019.01179","article-title":"Killer Ig-Like Receptors (KIRs): Their Role in NK Cell Modulation and Developments Leading to Their Clinical Exploitation","volume":"10","author":"Pende","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.medj.2025.100670_bib52","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1365-2567.2009.03208.x","article-title":"The extensive polymorphism of KIR genes","volume":"129","author":"Middleton","year":"2010","journal-title":"Immunology"},{"key":"10.1016\/j.medj.2025.100670_bib53","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1008906","article-title":"Epistatic interactions between killer immunoglobulin-like receptors and human leukocyte antigen ligands are associated with ankylosing spondylitis","volume":"16","author":"Hanson","year":"2020","journal-title":"PLoS Genet."},{"key":"10.1016\/j.medj.2025.100670_bib54","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.4049\/jimmunol.1601835","article-title":"Resurrecting KIR2DP1: A Key Intermediate in the Evolution of Human Inhibitory NK Cell Receptors That Recognize HLA-C","volume":"198","author":"Hilton","year":"2017","journal-title":"J. Immunol."},{"key":"10.1016\/j.medj.2025.100670_bib55","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0198-8859(91)90078-N","article-title":"Sequence analysis of HLA-Bw53, a common West African allele, suggests an origin by gene conversion of HLA-B35","volume":"30","author":"Allsopp","year":"1991","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.medj.2025.100670_bib56","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/BF02114973","article-title":"Allospecificities betweenHLA-Bw53 andHLA-B35 are generated by substitution of the residues associated with HLA-Bw4\/Bw6 public epitopes","volume":"32","author":"Hayashi","year":"1990","journal-title":"Immunogenetics"},{"key":"10.1016\/j.medj.2025.100670_bib57","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/QAD.0000000000001382","article-title":"Post-treatment control or treated controllers? Viral remission in treated and untreated primary HIV infection","volume":"31","author":"Martin","year":"2017","journal-title":"AIDS"},{"key":"10.1016\/j.medj.2025.100670_bib58","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1097\/QAD.0000000000001743","article-title":"Post-treatment controllers after treatment interruption in chronically HIV-infected patients","volume":"32","author":"Maggiolo","year":"2018","journal-title":"AIDS"},{"key":"10.1016\/j.medj.2025.100670_bib59","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1093\/infdis\/jis275","article-title":"HLA-B Signal Peptide Polymorphism Influences the Rate of HIV-1 Acquisition but Not Viral Load","volume":"205","author":"Merino","year":"2012","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.medj.2025.100670_bib60","first-page":"237","article-title":"Natural Killer Cell Receptor NKG2A\/HLA-E Interaction Dependent Differential Thymopoiesis of Hematopoietic Progenitor Cells Influences the Outcome of HIV Infection","volume":"2","author":"Yunis","year":"2007","journal-title":"J. Stem Cell."},{"key":"10.1016\/j.medj.2025.100670_bib61","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.3389\/fimmu.2017.01496","article-title":"Natural Killer Cell Interactions with Classical and Non-Classical Human Leukocyte Antigen Class I in HIV-1 Infection","volume":"8","author":"H\u00f6lzemer","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.medj.2025.100670_bib62","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1182\/blood-2010-03-273656","article-title":"Analyses of HLA-C-specific KIR repertoires in donors with group A and B haplotypes suggest a ligand-instructed model of NK cell receptor acquisition","volume":"117","author":"Schonberg","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.medj.2025.100670_bib63","doi-asserted-by":"crossref","first-page":"336","DOI":"10.3389\/fimmu.2012.00336","article-title":"Diverse functionality among human NK cell receptors for the C1 epitope of HLA-C: KIR2DS2, KIR2DL2, and KIR2DL3","volume":"3","author":"Moesta","year":"2012","journal-title":"Front. Immunol."},{"key":"10.1016\/j.medj.2025.100670_bib64","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1146\/annurev.genom.7.080505.115726","article-title":"The Killer Immunoglobulin-Like Receptor Gene Cluster: Tuning the Genome for Defense","volume":"7","author":"Bashirova","year":"2006","journal-title":"Annu. Rev. Genom. Hum. Genet."},{"key":"10.1016\/j.medj.2025.100670_bib65","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1111\/j.1600-6143.2008.02431.x","article-title":"Natural killer cell receptor repertoire and their ligands, and the risk of CMV infection after kidney transplantation","volume":"8","author":"Hadaya","year":"2008","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.medj.2025.100670_bib66","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1111\/j.1600-6143.2008.02242.x","article-title":"The number of activating KIR genes inversely correlates with the rate of CMV infection\/reactivation in kidney transplant recipients","volume":"8","author":"Stern","year":"2008","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.medj.2025.100670_bib67","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.bbmt.2008.11.030","article-title":"The effect of single and combined activating killer immunoglobulin-like receptor genotypes on cytomegalovirus infection and immunity after hematopoietic cell transplantation","volume":"15","author":"Zaia","year":"2009","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.medj.2025.100670_bib68","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1084\/jem.20091386","article-title":"HLA-B\u221735-Px-mediated acceleration of HIV-1 infection by increased inhibitory immunoregulatory impulses","volume":"206","author":"Huang","year":"2009","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.medj.2025.100670_bib69","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1004196","article-title":"LILRB2 Interaction with HLA Class I Correlates with Control of HIV-1 Infection","volume":"10","author":"Bashirova","year":"2014","journal-title":"PLoS Genet."},{"key":"10.1016\/j.medj.2025.100670_bib70","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1084\/jem.20021747","article-title":"Stress signals activate natural killer cells","volume":"196","author":"Long","year":"2002","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.medj.2025.100670_bib71","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1365-2796.2008.02045.x","article-title":"NK cells in HIV-1 infection: evidence for their role in the control of HIV-1 infection","volume":"265","author":"Alter","year":"2009","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.medj.2025.100670_bib72","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1097\/QAD.0000000000001645","article-title":"Natural killer cells in HIV-1 infection and therapy","volume":"31","author":"Mikulak","year":"2017","journal-title":"AIDS"},{"key":"10.1016\/j.medj.2025.100670_bib73","doi-asserted-by":"crossref","first-page":"4296","DOI":"10.1182\/blood-2006-08-040238","article-title":"Distinctive NK-cell receptor repertoires sustain high-level constitutive NK-cell activation in HIV-exposed uninfected individuals","volume":"109","author":"Ravet","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.medj.2025.100670_bib74","doi-asserted-by":"crossref","first-page":"5663","DOI":"10.4049\/jimmunol.171.11.5663","article-title":"Cutting edge: increased NK cell activity in HIV-1-exposed but uninfected Vietnamese intravascular drug users","volume":"171","author":"Scott-Algara","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.medj.2025.100670_bib75","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1038\/nm.4421","article-title":"Natural killer cells migrate into and control simian immunodeficiency virus replication in lymph node follicles in African green monkeys","volume":"23","author":"Huot","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.medj.2025.100670_bib76","doi-asserted-by":"crossref","first-page":"e42","DOI":"10.1016\/S2352-3018(22)00302-2","article-title":"Immunological and virological findings in a patient with exceptional post-treatment control: a case report","volume":"10","author":"Climent","year":"2023","journal-title":"Lancet. HIV"},{"key":"10.1016\/j.medj.2025.100670_bib77","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2218960120","article-title":"HIV post-treatment controllers have distinct immunological and virological features","volume":"120","author":"Etemad","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.medj.2025.100670_bib78","doi-asserted-by":"crossref","first-page":"9909","DOI":"10.1128\/JVI.01546-15","article-title":"A Higher Frequency of NKG2A+ than of NKG2A\u2212 NK Cells Responds to Autologous HIV-Infected CD4 Cells irrespective of Whether or Not They Coexpress KIR3DL1","volume":"89","author":"Lisovsky","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.medj.2025.100670_bib79","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/cei.12187","article-title":"Dimorphic HLA-B signal peptides differentially influence HLA-E- and natural killer cell-mediated cytolysis of HIV-1-infected target cells","volume":"174","author":"Merino","year":"2013","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.medj.2025.100670_bib80","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nature10237","article-title":"HIV-1 adaptation to NK-cell-mediated immune pressure","volume":"476","author":"Alter","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.medj.2025.100670_bib81","doi-asserted-by":"crossref","first-page":"6798","DOI":"10.1128\/JVI.00256-09","article-title":"HLA Class I Subtype-Dependent Expansion of KIR3DS1+ and KIR3DL1+ NK Cells during Acute Human Immunodeficiency Virus Type 1 Infection","volume":"83","author":"Alter","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.medj.2025.100670_bib82","doi-asserted-by":"crossref","DOI":"10.1038\/cti.2017.22","article-title":"NKG2C+ memory-like NK cells contribute to the control of HIV viremia during primary infection: Optiprim-ANRS 147","volume":"6","author":"Gondois-Rey","year":"2017","journal-title":"Clinical & Translational Immunology"},{"key":"10.1016\/j.medj.2025.100670_bib83","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1038\/s41467-022-29511-1","article-title":"Transient viral exposure drives functionally-coordinated humoral immune responses in HIV-1 post-treatment controllers","volume":"13","author":"Molinos-Albert","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.medj.2025.100670_bib84","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/cmi.2013.10","article-title":"NK cell-based immunotherapy for malignant diseases","volume":"10","author":"Cheng","year":"2013","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.medj.2025.100670_bib85","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2015.00605","article-title":"Natural Killer Cell-Based Therapies Targeting Cancer: Possible Strategies to Gain and Sustain Anti-Tumor Activity","volume":"6","author":"Dahlberg","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.medj.2025.100670_bib86","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ebiom.2019.05.045","article-title":"Entering a new era of harnessing natural killer cell responses in HIV infection","volume":"44","author":"Peppa","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.medj.2025.100670_bib87","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1038\/s41467-021-23189-7","article-title":"IL-21 and IFNalpha therapy rescues terminally differentiated NK cells and limits SIV reservoir in ART-treated macaques","volume":"12","author":"Harper","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.medj.2025.100670_bib88","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1089\/aid.2020.0243","article-title":"Safety, Immune, and Antiviral Effects of Pegylated Interferon Alpha 2b Administration in Antiretroviral Therapy-Suppressed Individuals: Results of Pilot Clinical Trial","volume":"37","author":"Papasavvas","year":"2021","journal-title":"AIDS Res. Hum. Retrovir."},{"key":"10.1016\/j.medj.2025.100670_bib89","doi-asserted-by":"crossref","first-page":"6588","DOI":"10.4049\/jimmunol.177.10.6588","article-title":"Cutting edge: resistance to HIV-1 infection among African female sex workers is associated with inhibitory KIR in the absence of their HLA ligands","volume":"177","author":"Jennes","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.medj.2025.100670_bib90","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s00251-016-0906-1","article-title":"The effects of killer cell immunoglobulin-like receptor (KIR) genes on susceptibility to HIV-1 infection in the Polish population","volume":"68","author":"Zwolinska","year":"2016","journal-title":"Immunogenetics"},{"key":"10.1016\/j.medj.2025.100670_bib93","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/978-1-60761-362-6_25","article-title":"KIR genotyping by multiplex PCR-SSP","volume":"612","author":"Kulkarni","year":"2010","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.medj.2025.100670_bib91","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1093\/cid\/civ171","article-title":"Impact of the Timing of Initiation of Antiretroviral Therapy During Primary HIV-1 Infection on the Decay of Cell-Associated HIV-DNA","volume":"60","author":"Laanani","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.medj.2025.100670_bib92","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/aed12a66-9c76-4e49-806b-881a2fe23bba","article-title":"Is clinical practice concordant with the changes in guidelines for antiretroviral therapy initiation during primary and chronic HIV-1 infection? The ANRS PRIMO and COPANA cohorts","volume":"8","author":"Krastinova","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.medj.2025.100670_bib94","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/nprot.2010.73","article-title":"Ex vivo T cell-based HIV suppression assay to evaluate HIV-specific CD8+ T-cell responses","volume":"5","author":"Saez-Cirion","year":"2010","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.medj.2025.100670_bib95","doi-asserted-by":"crossref","first-page":"10074","DOI":"10.1128\/JVI.74.21.10074-10080.2000","article-title":"Human immunodeficiency virus type 1 spinoculation enhances infection through virus binding","volume":"74","author":"O'Doherty","year":"2000","journal-title":"J. Virol."}],"container-title":["Med"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666634025000972?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666634025000972?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T22:40:45Z","timestamp":1756248045000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666634025000972"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":95,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S2666634025000972"],"URL":"https:\/\/doi.org\/10.1016\/j.medj.2025.100670","relation":{},"ISSN":["2666-6340"],"issn-type":[{"value":"2666-6340","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A genetic fingerprint associated with durable HIV remission after interruption of antiretroviral treatment: ANRS VISCONTI\/PRIMO","name":"articletitle","label":"Article Title"},{"value":"Med","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medj.2025.100670","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100670"}}